🇺🇸 FDA
Patent

US 10729693

Compositions and methods for the treatment of endometriosis

granted A61KA61K31/505A61K31/519

Quick answer

US patent 10729693 (Compositions and methods for the treatment of endometriosis) held by The Board of Regents of the University of Texas System expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/505, A61K31/519, A61P, A61P15/00